Semler Scientific (Semler Scientific) Change In Working Capital : $0.40 Mil (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Semler Scientific Change In Working Capital?

Semler Scientific's change in working capital for the quarter that ended in Mar. 2024 was $-0.65 Mil.

Semler Scientific's change in working capital for the fiscal year that ended in Dec. 2023 was $-3.74 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Semler Scientific Change In Working Capital Historical Data

The historical data trend for Semler Scientific's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Semler Scientific Change In Working Capital Chart

Semler Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Working Capital

Get a 7-Day Free Trial

0.89

-1.73

-4.58

1.67

-3.74

Semler Scientific Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Working Capital	Get a 7-Day Free Trial															-4.79	4.88	-1.07	-2.76	-0.65

Semler Scientific Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.40 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Semler Scientific Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Semler Scientific's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Semler Scientific (Semler Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Semler Scientific Inc (NAS:SMLR) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

6FA:Germany

Address

2340-2348 Walsh Avenue, Suite 2344, Santa Clara, CA, USA, 95051

Website

http://www.semlerscientific.com

Semler Scientific Inc is a US-based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.

Executives

Eric Semler	director	4625 FIELDSTON ROAD, BRONX NY 10471
Renae Cormier	officer: Chief Financial Officer	C/O SEMLER SCIENTIFIC, INC., 2340-2348 WALSH AVE, SUITE 2344, SANTA CLARA CA 95051
Douglas Murphy-chutorian	director, 10 percent owner, officer: Chief Executive Officer	C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112
Wayne T Pan	director	2330 NW EVERETT STREET, PORTLAND OR 97210
William H.c. Chang & Diana Shon Chang Ttee Chang Family Trust U/a Dtd 10/23/2006	10 percent owner	C/O SEMLER SCIENTIFIC, INC., 911 BERN CT., SAN JOSE CA 95112
Chang 2020 Delaware Lp	10 percent owner	C/O SEMLER SCIENTIFIC, INC., 2340-2348 WALSH AVENUE, SUITE 2344, SANTA CLARA CA 95051
Arthur N Leibowitz	director	C/O I-TRAX INC, ONE LOGAN SQUARE STE 2615, PHILADELPHIA PA 19103
Chang 2020 Gp Llc	10 percent owner	C/O SEMLER SCIENTIFIC, INC., 2340-2348 WALSH AVENUE, STE. 2344, SANTA CLARA CA 95051
Cindy Moon	director	C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SAN JOSE CA 95112
Daniel S Messina	director	C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, STE. 110, SAN JOSE Z4 95112
Daniel E Conger	officer: Vice President, Finance	C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112
William H Chang	10 percent owner	C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112
Diana Shon Chang	10 percent owner	1301 SHOREWAY RD., SUITE 150, BELMONT CA 94002
Andrew B. Weinstein	officer: Senior VP, Finance and Acct.	C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112
Herbert J Semler	director, 10 percent owner	C/O SEMLER SCIENTIFIC, INC., 2330 NW EVERETT ST., PORTLAND OR 97210